標(biāo)題: Titlebook: Antiphospholipid Syndrome; Current Research Hig Doruk Erkan,Michael D. Lockshin Book 2017 Springer International Publishing AG 2017 antipho [打印本頁] 作者: gratuity 時間: 2025-3-21 18:39
書目名稱Antiphospholipid Syndrome影響因子(影響力)
作者: GRIEF 時間: 2025-3-21 22:49 作者: 不可知論 時間: 2025-3-22 01:08
Doruk Erkan,Michael D. LockshinA comprehensive and thorough collection of essays on all aspects of APS by internationally recognized authorities in the field.Presents the latest state-of-the-art information about evidence-based pra作者: ALE 時間: 2025-3-22 07:41
http://image.papertrans.cn/a/image/158644.jpg作者: Lipoprotein 時間: 2025-3-22 09:50 作者: 建筑師 時間: 2025-3-22 13:01 作者: 仔細(xì)閱讀 時間: 2025-3-22 18:59
Data Process of Electromagnetic Information,have been described; this chapter reviews the evidence that these plasma proteins, e.g. β.-glycoprotein I, play a role in the clinical manifestations of antiphospholipid syndrome (APS). Moreover, the chapter discusses why these proteins become prothrombotic when the autoantibodies are present.作者: Coterminous 時間: 2025-3-22 22:04 作者: 配偶 時間: 2025-3-23 02:52 作者: 充滿裝飾 時間: 2025-3-23 06:14
Microwave Radiometry and Thermographythat aPL have wide-ranging effects on vascular cells, coagulation factors, and regulators of the coagulation cascade that produce a procoagulant phenotype. However, the molecular mechanisms underlying these processes remain incompletely understood. Inflammation serves as a necessary link between the作者: expeditious 時間: 2025-3-23 11:45 作者: compassion 時間: 2025-3-23 14:51
Charge in Electromagnetic Wave, syndrome (APS) has a clear definition for classification of patients with a limited spectrum of clinical and laboratory criteria, a broader spectrum of clinical manifestations exists, and thrombosis may be multifactorial. A standard definition of APS is challenging. Although data on epidemiology of作者: Countermand 時間: 2025-3-23 19:37
Charge in Electromagnetic Wave, I antibodies (aβ.GPI), and/or the lupus anticoagulant (LA) to satisfy the laboratory criterion for disease definition. However, over the past 20 years, several other non-criteria antiphospholipid antibodies (aPL) directed to other proteins of the coagulation cascade (i.e., prothrombin and/or phosph作者: unstable-angina 時間: 2025-3-23 22:10 作者: floaters 時間: 2025-3-24 03:16 作者: acrimony 時間: 2025-3-24 07:17 作者: 驕傲 時間: 2025-3-24 11:09
Vacuum Polarization, Source- and Otherwise,n a patient’s life. Several trials have been designed to improve gestational outcomes in women with APS; the combination of low-dose aspirin and heparin has emerged as the standard treatment for the disease, although not without criticism by some experts. Limitations, such as small number of patient作者: 外科醫(yī)生 時間: 2025-3-24 16:29 作者: BAIT 時間: 2025-3-24 20:39 作者: Chivalrous 時間: 2025-3-25 02:13
Data Process of Electromagnetic Information,have been described; this chapter reviews the evidence that these plasma proteins, e.g. β.-glycoprotein I, play a role in the clinical manifestations of antiphospholipid syndrome (APS). Moreover, the chapter discusses why these proteins become prothrombotic when the autoantibodies are present.作者: FEAS 時間: 2025-3-25 05:53
entativesfrom different disciplines gather to discuss the recent advances in APS. The conference intends to cover basic aspects of APS, such as pathogenesis, origins, genetics, intracellular and molecular event978-3-319-85662-9978-3-319-55442-6作者: 自傳 時間: 2025-3-25 09:17
Recent Advances in Understanding of the Genetics of Antiphospholipid Syndrome identify and characterize genes associated with the development of aPL should improve our understanding of this complex autoimmune disorder and regarding which patients with aPL are likely to develop clinical manifestations of the syndrome.作者: mercenary 時間: 2025-3-25 13:31
Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Testsature and conducted new studies between 2013 and 2016; the conclusions were presented at a special session during the 15th International Congress on aPL (., North Cyprus, September 2016). This paper updates our recommendations.作者: Migratory 時間: 2025-3-25 16:14
Prevention and Treatment of Thrombotic Antiphospholipid Syndromem without arterial thrombosis are adequately treated with warfarin administered to a target INR of 2.0–3.0. There is a lack of good-quality evidence to support any particular therapeutic strategy for patients with a history of arterial thrombosis. Standard-intensity warfarin (INR 2.0–3.0) is used in作者: collagenase 時間: 2025-3-25 20:43
Microwave Radiometry and Thermography identify and characterize genes associated with the development of aPL should improve our understanding of this complex autoimmune disorder and regarding which patients with aPL are likely to develop clinical manifestations of the syndrome.作者: podiatrist 時間: 2025-3-26 01:38
Charge in Electromagnetic Wave,ature and conducted new studies between 2013 and 2016; the conclusions were presented at a special session during the 15th International Congress on aPL (., North Cyprus, September 2016). This paper updates our recommendations.作者: 曲解 時間: 2025-3-26 04:38
Convexity Properties of Coulomb Systems,m without arterial thrombosis are adequately treated with warfarin administered to a target INR of 2.0–3.0. There is a lack of good-quality evidence to support any particular therapeutic strategy for patients with a history of arterial thrombosis. Standard-intensity warfarin (INR 2.0–3.0) is used in作者: 歡樂中國 時間: 2025-3-26 09:54
Book 2017nal Congress on Antiphospholipid Antibodies, held every 3 years, is the venue where representativesfrom different disciplines gather to discuss the recent advances in APS. The conference intends to cover basic aspects of APS, such as pathogenesis, origins, genetics, intracellular and molecular event作者: 懶惰人民 時間: 2025-3-26 13:57 作者: 史前 時間: 2025-3-26 20:17 作者: notification 時間: 2025-3-26 23:39 作者: Affectation 時間: 2025-3-27 03:34
latest state-of-the-art information about evidence-based praThis new edition is a comprehensive and updated resource on antiphospholipid syndrome (APS), which is an autoimmune disorder. In APS, the body recognizes certain normal components of blood and/or cell membranes as foreign substances and pro作者: JOT 時間: 2025-3-27 06:19
Charge in Electromagnetic Wave,of clinical manifestations exists, and thrombosis may be multifactorial. A standard definition of APS is challenging. Although data on epidemiology of APS are limited, being based on small scale studies or studies with methodological limitations, this chapter gives the best synthesis possible today.作者: CUMB 時間: 2025-3-27 11:45
S. Ciulli,C. Pomponiu,I. Sabba Stefanescumanagement of some manifestations of APS remains empirical and with limited evidence-based data. In this chapter, together with a concise literature review, each situation is illustrated by a real clinical case followed by an expert discussion. Potential future treatment strategies for aPL-positive patients are also discussed.作者: cipher 時間: 2025-3-27 16:34
S. Ciulli,C. Pomponiu,I. Sabba Stefanescues (aPL) with/without aPL-related clinical symptoms. Since 2010, through the dedication APS ACTION members, collaborative international projects are underway. This chapter provides a summary of the organization’s structure, ongoing research efforts, and recent accomplishments and discusses future directions.作者: Injunction 時間: 2025-3-27 21:24 作者: 含沙射影 時間: 2025-3-28 00:26
Treatment of Non-criteria Manifestations in Antiphospholipid Syndromemanagement of some manifestations of APS remains empirical and with limited evidence-based data. In this chapter, together with a concise literature review, each situation is illustrated by a real clinical case followed by an expert discussion. Potential future treatment strategies for aPL-positive patients are also discussed.作者: filial 時間: 2025-3-28 05:12
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION)es (aPL) with/without aPL-related clinical symptoms. Since 2010, through the dedication APS ACTION members, collaborative international projects are underway. This chapter provides a summary of the organization’s structure, ongoing research efforts, and recent accomplishments and discusses future directions.作者: Needlework 時間: 2025-3-28 06:17
Disease and Risk Measurement Criteria in Antiphospholipid Syndromermanent damage may occur, a damage index for APS (DIAPS) has been developed and validated. The consequences of permanent damage due to thrombosis in APS patients decrease the health-related quality of life (HRQoL).作者: HEW 時間: 2025-3-28 11:07 作者: 冬眠 時間: 2025-3-28 17:57 作者: EVEN 時間: 2025-3-28 22:26
Microwave Radiometry and Thermography experts in the field, for instance, the relative importance of various mechanisms in the precipitation of thrombosis. Finally, we outline ongoing studies, namely, those presented at the recent 15th International Congress on aPL and our vision of the future direction of APS thrombosis research.作者: 貴族 時間: 2025-3-28 23:57 作者: Hyperalgesia 時間: 2025-3-29 03:31
Origin of Antiphospholipid Antibodiesor commensal microorganisms, and on the appropriate genetic background, pathogenic aPL may emerge. This chapter outlines the environmental and immune factors leading to aPL and antiphospholipid syndrome.作者: 錢財 時間: 2025-3-29 08:52
Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis experts in the field, for instance, the relative importance of various mechanisms in the precipitation of thrombosis. Finally, we outline ongoing studies, namely, those presented at the recent 15th International Congress on aPL and our vision of the future direction of APS thrombosis research.作者: 灰心喪氣 時間: 2025-3-29 13:31 作者: Iniquitous 時間: 2025-3-29 16:24 作者: Vasoconstrictor 時間: 2025-3-29 21:55 作者: novelty 時間: 2025-3-30 02:23 作者: 歡樂中國 時間: 2025-3-30 06:04 作者: connoisseur 時間: 2025-3-30 09:21
History of Antiphospholipid AntibodyS) contains nine phases. We base this history on personal memory (primarily that of MDL) and on conversations with the early North American leaders, Samuel Rapaport, Lawrence Shulman, Sandor Shapiro, Donato Alarcon-Segovia, and Carl Alving; others have seen the history differently. The nine phases e作者: euphoria 時間: 2025-3-30 13:52 作者: CHANT 時間: 2025-3-30 18:22
